57 related articles for article (PubMed ID: 28092843)
1. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
2. Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1).
Dehbokri SG; Noorolyai S; Baghbani E; Moghaddamneshat N; Javaheri T; Baradaran B
Mol Biol Rep; 2024 May; 51(1):646. PubMed ID: 38727931
[TBL] [Abstract][Full Text] [Related]
3. BACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2.
Chen Y; Jin L; Ma Y; Liu Y; Zhu Q; Huang Y; Feng W
Cancer Sci; 2023 Sep; 114(9):3568-3582. PubMed ID: 37311571
[TBL] [Abstract][Full Text] [Related]
4. The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle.
Warnatz HJ; Schmidt D; Manke T; Piccini I; Sultan M; Borodina T; Balzereit D; Wruck W; Soldatov A; Vingron M; Lehrach H; Yaspo ML
J Biol Chem; 2011 Jul; 286(26):23521-32. PubMed ID: 21555518
[TBL] [Abstract][Full Text] [Related]
5. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients.
Lee U; Frankenberger C; Yun J; Bevilacqua E; Caldas C; Chin SF; Rueda OM; Reinitz J; Rosner MR
PLoS One; 2013; 8(12):e82125. PubMed ID: 24349199
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.
Faltus T; Yuan J; Zimmer B; Krämer A; Loibl S; Kaufmann M; Strebhardt K
Neoplasia; 2004; 6(6):786-95. PubMed ID: 15720805
[TBL] [Abstract][Full Text] [Related]
7. BACH1 Ser919Pro variant and breast cancer risk.
Vahteristo P; Yliannala K; Tamminen A; Eerola H; Blomqvist C; Nevanlinna H
BMC Cancer; 2006 Jan; 6():19. PubMed ID: 16430786
[TBL] [Abstract][Full Text] [Related]
8. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
[TBL] [Abstract][Full Text] [Related]
9. BACH1 Loss Exerts Antitumor Effects on Mantle Cell Lymphoma Cells via Inducing a Tumor-Intrinsic Innate Immune Response and Cell-Cycle Arrest.
Li G; Feng M; Zhang Z; Liu J; Zhang H
Mol Cancer Res; 2023 Dec; 21(12):1274-1287. PubMed ID: 37713314
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Worth of Nrf2/BACH1/HO-1 Protein Expression in the Development of Breast Cancer.
Barnes P; Agbo E; Wang J; Amoani B; Kwaku Opoku Y; Okyere P; Saahene RO
Med Princ Pract; 2023; 32(6):369-378. PubMed ID: 37827129
[TBL] [Abstract][Full Text] [Related]
11. Nonmonotone invasion landscape by noise-aware control of metastasis activator levels.
Wan Y; Cohen J; Szenk M; Farquhar KS; Coraci D; Krzysztoń R; Azukas J; Van Nest N; Smashnov A; Chern YJ; De Martino D; Nguyen LC; Bien H; Bravo-Cordero JJ; Chan CH; Rosner MR; Balázsi G
Nat Chem Biol; 2023 Jul; 19(7):887-899. PubMed ID: 37231268
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis.
Li ZF; Xu WW; Li JD; Tao FL; Chen JX; Xu JH
Sci Prog; 2020; 103(1):36850419891046. PubMed ID: 31791191
[TBL] [Abstract][Full Text] [Related]
13. A systems-level analysis of the mutually antagonistic roles of RKIP and BACH1 in dynamics of cancer cell plasticity.
Shyam S; Ramu S; Sehgal M; Jolly MK
J R Soc Interface; 2023 Nov; 20(208):20230389. PubMed ID: 37963558
[TBL] [Abstract][Full Text] [Related]
14. Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1.
Moreno R; Casares L; Higgins M; Ali KX; Honda T; Wiel C; Sayin VI; Dinkova-Kostova AT; de la Vega L
Free Radic Biol Med; 2022 Oct; 191():203-211. PubMed ID: 36084789
[TBL] [Abstract][Full Text] [Related]
15. Tarin-Loaded Nanoliposomes Activate Apoptosis and Autophagy and Inhibit the Migration of Human Mammary Adenocarcinoma Cells.
Cardoso RV; Pereira PR; Freitas CS; Mattos ÉBA; Silva AVF; Midlej VDV; Vericimo MA; Conte-Júnior CA; Paschoalin VMF
Int J Nanomedicine; 2023; 18():6393-6408. PubMed ID: 37954458
[TBL] [Abstract][Full Text] [Related]
16. Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer.
Li X; Liang Z; Pan J; Zhang M; Liu J; Hu R; Liao C
BMC Cancer; 2024 Mar; 24(1):328. PubMed ID: 38468240
[TBL] [Abstract][Full Text] [Related]
17. Effect of Emi1 gene silencing on the proliferation and invasion of human breast cancer cells.
Kuang Y; Huang S; Tang S; Zhuo Z; Linghu K
BMC Mol Cell Biol; 2023 Dec; 24(1):34. PubMed ID: 38041032
[TBL] [Abstract][Full Text] [Related]
18. Designing Nanomedicines for Breast Cancer Therapy.
Abbasi Dezfouli S; Rajendran AP; Claerhout J; Uludag H
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892241
[TBL] [Abstract][Full Text] [Related]
19. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel.
Riazi-Tabrizi N; Khalaj-Kondori M; Safaei S; Amini M; Hassanian H; Maghsoudi M; Hasani S; Baradaran B
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37740817
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Rapanone and Nectandrin B as novel inhibitors for targeting the metastatic regulator protein BACH1 using breast cancer cell line Mcf-7.
Arunachalam A; Sankar M; Pandi B; Paul S; Thilagar S
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37747058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
